Search Results - "Christensen, Inge T"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Differential Interactions of Nateglinide and Repaglinide on the Human β-Cell Sulphonylurea Receptor 1 by HANSEN, Ann Maria K, CHRISTENSEN, Inge T, HANSEN, John Bondo, CARR, Richard D, ASHCROFT, Frances M, WAHL, Philip

    Published in Diabetes (New York, N.Y.) (01-09-2002)
    “…Differential Interactions of Nateglinide and Repaglinide on the Human β-Cell Sulphonylurea Receptor 1 Ann Maria K. Hansen 1 , Inge T. Christensen 1 , John…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Homology building as a means to define antigenic epitopes on dihydrofolate reductase (DHFR) from Plasmodium falciparum by Alifrangis, Michael, Christensen, Inge T, Jørgensen, Flemming S, Rønn, Anita M, Weng, Jimmy E, Chen, Ming, Bygbjerg, Ib C, Sirawaraporn, Worachart, Palarasah, Yaseelan, Koch, Claus

    Published in Malaria journal (12-06-2004)
    “…The aim of this study was to develop site-specific antibodies as a tool to capture Plasmodium falciparum-dihydrofolate reductase (Pf-DHFR) from blood samples…”
    Get full text
    Journal Article
  4. 4

    Computational prediction of solubilizers’ effect on partitioning by Hoest, Jan, Christensen, Inge T., Jørgensen, Flemming S., Hovgaard, Lars, Frokjaer, Sven

    Published in International journal of pharmaceutics (01-02-2007)
    “…A computational model for the prediction of solubilizers’ effect on drug partitioning has been developed. Membrane/water partitioning was evaluated by means of…”
    Get full text
    Journal Article
  5. 5

    Structure−Property Model for Membrane Partitioning of Oligopeptides by Alifrangis, Lene Hjorth, Christensen, Inge T, Berglund, Anders, Sandberg, Maria, Hovgaard, Lars, Frokjaer, Sven

    Published in Journal of medicinal chemistry (13-01-2000)
    “…The aim of this study was to develop a structure−property model for membrane partitioning of oligopeptides using statistical design methods and multivariate…”
    Get full text
    Journal Article
  6. 6

    Assessing the relative importance of the biophysical properties of amino acid substitutions associated with human genetic disease by Terp, Bent N., Cooper, David N., Christensen, Inge T., Jørgensen, Flemming S., Bross, Peter, Gregersen, Niels, Krawczak, Michael

    Published in Human mutation (01-08-2002)
    “…The inclusion of a mutation in a pathology‐based database such as the Human Gene Mutation Database (HGMD) is a two‐stage process: first, the mutation must…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid by Christensen, Inge T, Ebert, Bjarke, Madsen, Ulf, Nielsen, Birgitte, Brehm, Lotte, Krogsgaard-Larsen, Povl

    Published in Journal of medicinal chemistry (01-09-1992)
    “…The 3-isoxazolol amino acid (RS)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA, 2) and the isomeric compound…”
    Get full text
    Journal Article
  10. 10

    Differential interactions of nateglinide and repaglinide on the human [beta]-Cell sulphonylurea receptor 1 by Hansen, Ann Maria K, Christensen, Inge T, Hansen, John Bondo, Carr, Richard D, Ashcroft, Frances M, Wahl, Philip

    Published in Diabetes (New York, N.Y.) (01-09-2002)
    “…Repaglinide and nateglinide represent a new class of insulin secretagogues, structurally unrelated to sulphonylureas, that were developed for the treatment of…”
    Get full text
    Journal Article
  11. 11
  12. 12